Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

FDA Grants Orphan Drug Designation to Dauntless Pharmaceuticals' DP1038 for the Treatment of Acromegaly

Wednesday, January 31, 2018

Dauntless Pharmaceuticals Inc a privately held biopharmaceutical company focused on the development of specialty therapeutics announces that the US Food and Drug Administration FDA has granted orphan drug designation to DP the companys investigationa...

Upsher-Smith Receives FDA Approval For Bumetanide Tablets, USP

Wednesday, January 31, 2018

UpsherSmith Laboratories LLC UpsherSmith today announced that it has received US Food and Drug Administration FDA approval of its abbreviated new drug application ANDA for Bumetanide Tablets USP mg mg and mg Bumetanide Tablets are a generic versio...

CutisPharma Announces FDA Approval Of FIRVANQ™ For Treatment Of Clostridium Difficile Associated Diarrhea (CDAD) And Staphylococcus Aureus Colitis

Tuesday, January 30, 2018

CutisPharma announced today that the US Food and Drug Administration FDA has approved FIRVANQ vancomycin hydrochloride for oral solution for the treatment of Clostridium difficile associated diarrhea and enterocolitis caused by Staphylococcus aureus...

Takeda's Zika Virus Vaccine Receives FDA Fast-Track Designation

Tuesday, January 30, 2018

Takeda Pharmaceutical Company Limited today announced that the US Food and Drug Administration FDA has granted Fasttrack designation for TAK Takedas purified inactivated aluminum adjuvant vaccine against Zika virus The FDAs Fast Track designation...

CASI Pharmaceuticals Acquires ANDA Portfolio From Sandoz Inc. (Sandoz)

Monday, January 29, 2018

CASI Pharmaceuticals Inc a biopharmaceutical company dedicated to bringing quality pharmaceutical products to the Chinese and US markets announced today that it has acquired a portfolio of US FDAapproved abbreviated new drug applications ANDAs one A...

Chugai's HEMLIBRA® Gains Positive CHMP Opinion in Hemophilia A with Inhibitors

Monday, January 29, 2018

Chugai Pharmaceutical Co Ltd announced that Roche has received notification that the EU Committee for Medicinal Products for Human Use CHMP adopted a positive opinion for HEMLIBRA emicizumab for routine prophylaxis of bleeding episodes in people with...

Novartis exclusively licenses first ophthalmology gene therapy in all markets outside the US

Thursday, January 25, 2018

Novartis today announced a licensing agreement with Spark Therapeutics covering development registration and commercialization rights to voretigene neparvovec in markets outside the US Voretigene neparvovec known as LUXTURNATM voretigene neparvovecrz...

Astellas Completes Acquisition of Mitobridge, Inc.

Thursday, January 25, 2018

Astellas Pharma Inc announced that it has completed the acquisition of Mitobridge Inc Mitobridge and Mitobridge has become a wholly owned subsidiary of Astellas as of January US Eastern Time By exercising the option right to acquire Mitobridge A...

Cardiome Announces Expanded Label For Aggrastat® In China Including New Stemi Indication And High Dose Bolus Regimen

Wednesday, January 24, 2018

Cardiome Pharma Corp a revenuegenerating specialty pharmaceutical company focused on commercializing patentprotected hospital drugs today announced that the Chinese Center for Drug Evaluation CDE has approved an expansion of the indications for Aggra...

ChemDiv Announces Expansion of Multi-Year Hit Identification Collaboration with Janssen

Wednesday, January 24, 2018

ChemDiv Inc announced at the th Annual JP Morgan Healthcare Conference the expansion of its hit identification collaboration with Janssen Research Development LLC Janssen and extending it into finding potent antiinfective drug candidates Broadening...